ADAMTS13 inhibition to treat acquired von Willebrand syndrome during mechanical circulatory support device implantation
Journal of Thrombosis and Haemostasis(2022)
摘要
Hence, inhibition of ADAMTS13 could become a novel therapeutic strategy to manage aVWS in MCS device patients.
更多查看译文
关键词
acquired von Willebrand syndrome,ADAMTS13,bleeding,mechanical circulatory support,von Willebrand factor
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要